Stocktoria
BIO-TECHNE Corp TECH
BIO-TECHNE Corp financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B | $1.1B | $931.0M | $738.7M | $714.0M | $643.0M | $563.0M | $499.0M |
| Gross profit | $790.3M | $769.7M | $769.8M | $756.5M | $632.9M | $483.2M | $473.5M | $432.1M | $374.5M | $336.7M |
| SG&A expense | $588.5M | $466.4M | $378.4M | $372.8M | $325.0M | $260.6M | $264.4M | $240.6M | $200.4M | $140.9M |
| Operating income | $102.3M | $206.7M | $298.9M | $296.6M | $237.3M | $157.4M | $146.7M | $136.2M | $120.6M | $150.6M |
| Interest expense | — | — | $11.2M | $11.3M | $14.0M | $19.2M | $21.7M | $10.2M | $7.4M | $1.7M |
| Income tax | $25.1M | $17.6M | $53.2M | $38.3M | $8.6M | $47.2M | $15.9M | -$198,000 | $35.9M | $43.0M |
| Net income | $73.4M | $168.1M | $285.3M | $272.1M | $140.4M | $229.3M | $96.1M | $126.2M | $76.1M | $104.5M |
| EPS (diluted) | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $1.46 | $0.62 | $0.83 | $0.51 | $0.70 |
| Operating cash flow | $287.6M | $299.0M | $254.4M | $325.3M | $352.2M | $205.2M | $181.6M | $170.4M | $143.7M | $144.2M |
| Free cash flow | $256.6M | $236.1M | $216.1M | $280.4M | $307.9M | $153.5M | $156.2M | $149.4M | $128.5M | $127.3M |
| Cash & equivalents | $162.2M | $151.8M | $180.6M | $172.6M | $199.1M | $146.6M | $100.9M | $122.0M | $91.6M | $64.2M |
| Inventory | $189.4M | $179.7M | $171.6M | $141.1M | $116.7M | $103.2M | $91.0M | $85.6M | $85.6M | $57.1M |
| Total assets | $2.6B | $2.7B | $2.6B | $2.3B | $2.3B | $2.0B | $1.9B | $1.6B | $1.6B | $1.1B |
| Shareholders' equity | $1.9B | $2.1B | $2.0B | $1.7B | $1.6B | $1.4B | $1.2B | $1.1B | $949.6M | $879.3M |
Growth · year-over-year · Revenue CAGR 10.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +5.2% | +2.0% | +2.8% | +18.7% | +26.0% | +3.5% | +11.0% | +14.2% | +12.8% | +10.3% |
| Net income growth | -56.3% | -41.1% | +4.9% | +93.8% | -38.8% | +138.7% | -23.8% | +65.8% | -27.2% | -3.0% |
| EPS growth | -56.2% | -40.3% | +6.0% | +90.8% | -40.2% | +135.6% | -25.4% | +63.1% | -27.5% | -3.1% |
| Free cash flow growth | +8.7% | +9.2% | -22.9% | -8.9% | +100.6% | -1.8% | +4.5% | +16.3% | +1.0% | +6.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.